Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

1.65
Delayed Data
As of Feb 10
 +0.04 / +2.48%
Today’s Change
1.39
Today|||52-Week Range
9.37
-4.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
AssetsCash104.2M75.1M71.6M154.3M
 
 
 
 
 
Short Term Investment Cash35.9M-29.2M-3.5M82.7M
 
 
 
 
 
Cash & Short Term Investments205.5M188.6M175.1M233.4M
 
 
 
 
 
 
ReceivablesReceivables2.6M4.5M6.8M4.6M
 
 
 
 
 
 
InventoriesInventories1.2M1.4M4.9M11.1M
 
 
 
 
 
 
Current AssetsOther Current Assets2.0M1.8M2.6M2.8M
 
 
 
 
 
Current Assets211.3M196.4M189.3M251.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.9M2.9M2.9M3.1M
 
 
 
 
 
Depreciation-2.1M-2.1M-2.2M-2.2M
 
 
 
 
 
Other Assets621.0K612.0K882.0K1.4M
 
 
 
 
 
Total Assets213.0M198.0M191.2M254.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable4.2M2.5M6.6M3.9M
 
 
 
 
 
Accrued Expenses12.6M13.3M19.2M17.7M
 
 
 
 
 
Other Current Liabilities20.8M21.5M27.4M27.7M
 
 
 
 
 
Other Liabilities29.7M25.9M36.6M35.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt83.9M84.9M86.0M87.0M
 
 
 
 
 
Deferred Taxes-547.0K-547.0K-547.0K-547.0K
 
 
 
 
 
Other Liabilities354.0K305.0K258.0K206.0K
 
 
 
 
 
Total Liabilities190.6M185.7M195.4M208.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity22.3M12.3M-4.2M46.2M
 
 
 
 
 
Total Shareholder Equity22.3M12.3M-4.2M46.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding123.5M124.9M125.4M145.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.